AIA
ALXN

AIMZ Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

AIMZ Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29,485
Closed -$5.42M – 116
2021
Q2 		$5.42M Sell
29,485
-150
-0.5% -$25.7K 2.43% 10
2021
Q1 		$4.53M Sell
29,635
-130
-0.4% -$20.1K 2.22% 10
2020
Q4 		$4.65M Sell
29,765
-600
-2% -$77.1K 2.44% 7
2020
Q3 		$3.48M Sell
30,365
-810
-3% -$87.4K 2.08% 14
2020
Q2 		$3.5M Sell
31,175
-90
-0.3% -$9.55K 2.27% 10
2020
Q1 		$2.81M Buy
31,265
+6,060
+24% +$595K 2.18% 15
2019
Q4 		$2.73M Hold
25,205
– – 1.76% 18
2019
Q3 		$2.47M Buy
+25,205
New +$2.84M 1.7% 20

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return